J&J Phase 3: Apalutamide + Hormone Therapy Before & After Surgery Improves Prostate Cancer Outcomes

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced results from the final analysis of the Phase 3 PROTEUS study, evaluating apalutamide plus hormone therapy (androgen deprivation therapy,...